Strongyloides stercoralis, strongyloidiasis, emodepside, ivermectin, phase 2a trial
ivermectin, moxidectin, Strongyloides stercoralis, strongyloidiasis
institutional research capacity strengthening, health research in low resource settings, research management, higher education institution, governance and strategy, funding organization, funding strategy, low- and middle-income countries